Abstract
As nutritional technology advanced, scientists have been able to synthesize and manufacture all known nutrients, and many of their metabolic by-products, essential to human physiology. Many of these substances are theorized to possess ergogenic potential when take in quantities or forms normally not found in typical foods or diets. Research, although limited in most cases, supports the ergogenicity of some nutrients (e.g., creatine) when consumed in substantial amounts, suggesting such nutrients may function as drugs or nutraceuticals. The International Olympic Committee (IOC) doping legislation stipulates that any physiologic substance taken in abnormal quantity with the intention of artificially and unfairly increasing performance should be construed as doping, violating the ethics of sport performance. Given this stipulation, the IOC and other athletic-governing organizations should consider the legality and ethics underlying the use of ergogenic nutraceuticals in sport.
Subject
Public Health, Environmental and Occupational Health,Endocrinology,Medicine (miscellaneous),Food Science
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献